Recurrence of Bacterial Vaginosis Is Significantly Associated With Posttreatment Sexual Activities and Hormonal Contraceptive Use
Open Access
- 12 December 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 56 (6) , 777-786
Abstract
Background. Bacterial vaginosis (BV) recurrence posttreatment is common. Our aim was to determine if behaviors were associated with BV recurrence in women in a randomized controlled trial (RCT). Methods. Symptomatic 18- to 50-year-old females with BV (≥3 Amsel criteria and Nugent score [NS] = 4–10) were enrolled in a 3-arm randomized double-blind RCT Melbourne Sexual Health Centre, Australia, in 2009–2010. All 450 participants received oral metronidazole (7 days) and were equally randomized to vaginal clindamycin, lactobacillus-vaginal probiotic or vaginal placebo. At 1, 2, 3, and 6 months, participants self-collected vaginal smears and completed questionnaires. Primary endpoint was NS = 7–10. Cox regression was used to estimate hazard ratios (HRs) for risk of BV recurrence associated with baseline and longitudinal characteristics. Results. Four hundred four (90%) women with postrandomization data contributed to analyses. Cumulative 6-month BV recurrence was 28% (95% confidence interval [CI], 24%–33%) and not associated with treatment. After stratifying for treatment and adjusting for age and sex frequency, recurrence was associated with having the same pre-/posttreatment sexual partner (adjusted HR [AHR] = 1.9; 95% CI, 1.2–3.0), inconsistent condom use (AHR = 1.9; 95% CI, 1.0–3.3), and being non-Australian (AHR = 1.5; 95% CI, 1.0–2.1), and halved with use of an estrogen-containing contraceptive (AHR = 0.5; 95% CI, .3–.8). Conclusions. Risk of BV recurrence was increased with the same pre-/posttreatment sexual partner and inconsistent condom use, and halved with use of estrogen-containing contraceptives. Behavioral and contraceptive practices may modify the effectiveness of BV treatment. Clinical Trials Registration. ACTRN12607000350426.Keywords
This publication has 38 references indexed in Scilit:
- Bacterial Communities of the Coronal Sulcus and Distal Urethra of Adolescent MalesPLOS ONE, 2012
- Efficacy of Oral Metronidazole with Vaginal Clindamycin or Vaginal Probiotic for Bacterial Vaginosis: Randomised Placebo-Controlled Double-Blind TrialPLOS ONE, 2012
- Behavioral Predictors of Colonization withLactobacillus crispatusorLactobacillus jenseniiafter Treatment for Bacterial Vaginosis: A Cohort StudyInfectious Diseases in Obstetrics and Gynecology, 2012
- Effect of Sexual Activity on Vaginal Colonization With Hydrogen Peroxide-Producing Lactobacilli and Gardnerella vaginalisSexually Transmitted Diseases, 2011
- In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxideBMC Infectious Diseases, 2011
- Risks for Acquisition of Bacterial Vaginosis Among Women Who Report Sex with Women: A Cohort StudyPLOS ONE, 2010
- Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilliBMC Infectious Diseases, 2010
- The Effects of Circumcision on the Penis MicrobiomePLOS ONE, 2010
- Distribution of GenitalLactobacillusStrains Shared by Female Sex PartnersThe Journal of Infectious Diseases, 2009
- The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, UgandaAmerican Journal of Obstetrics and Gynecology, 2009